These events included nausea [20 percent (5 mg), 22 percent (10 mg), 40 percent (15 mg)], diarrhea [24 percent (5 and 10 mg), 32 percent (15 mg)] and vomiting [8 percent (5 mg), 16 percent (10 mg), 26 percent (15 mg)], which were mild to moderate and generally temporary, most often occurring during the titration period
PlexusDx serves all 50 states and accepts patients regardless of prior treatment history, making it an option for veterans the VA may have declined
See the retatrutide vs semaglutide vs tirzepatide comparison for the mechanism contrast, and how to dose tirzepatide for the dual-agonist parallel
Monitor closely if on multiple therapies
Clinical data shows that about 3% of Wegovy users experience hair loss [2]
PMID: 36 MareninovaOAJiaWGretlerSRHolthausCLThomasDDHPimientaMet al